Navigation Links
Xoft Signs Sales Development Agreement With Elekta
Date:1/29/2008

-invasive treatment of brain disorders, Elekta Axesse(TM) and Elekta Synergy(R) for stereotactic and image guided radiation therapy and radiosurgery as well as the MOSAIQ(TM) suite of software for image-enabled EMR and efficient management of clinical and patient data. With over 2,000 employees globally, the corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information about Elekta can be found at http://www.elekta.com.

About Xoft, Inc.

Xoft is developing leading-edge new technologies for the practice of radiation oncology through Electronic Brachytherapy, which utilizes proprietary miniaturized x-ray tube technology. The Axxent(R) Electronic Brachytherapy System, Xoft's first treatment system, is currently being used in Accelerated Partial Breast Irradiation (APBI) for the treatment of early-stage breast cancer. This solution provides a therapeutic dose of intracavitary radiation directly to the region at risk without the complex handling and resource logistics necessary when performing brachytherapy using radioactive isotopes.

Axxent is a registered trademark of Xoft, Inc.


'/>"/>
SOURCE Xoft, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
2. Breckenridge Pharmaceutical Signs Long Term Agreement with Helm AG (Hamburg, Germany)
3. Cambrex Signs Agreement To Acquire ProSyntest AS
4. CSC Signs Extension to Managed Applications Services Agreement With Sun Microsystems
5. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
6. Nationwide Respiratory Signs Preferred Pulse Oximetry Agreement with Masimo
7. Claimsnet Signs Electronic Transaction Services Agreement With Employee Benefit Services of San Antonio
8. Flagship Global Health Chairman Resigns
9. Skinvisible Signs Marketing Agreement for India
10. Cavidi Signs Agreement With the Clinton Foundation HIV/AIDS Initiative to Lower Costs of HIV Monitoring
11. Baxa Corporation Signs Strategic Reseller Agreement With MedKeeper for Web-Based Productivity Tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)... secondary life insurance market ranked 156 among ...merica on Inc. 500 list, BETHESDA, Md., Aug. 20 /...in the secondary life insurance market, announced ...ing insurance related company in the US by,Inc. ma...8 Inc. 500 list of,fastest growing companies in Am...
(Date:8/20/2008)...esidents Gain Access to High Quality Care as State...g. 20 /PRNewswire-USNewswire/ -- Patients who suff...splant will no longer have to,seek that highly spe...p,care outside the borough of the Bronx. Area pati...gh-quality care locally, without having to travel,...
(Date:8/20/2008)...PRINGS, Pa., Aug. 20 /PRNewswire-USNewswire/ -- Go... agricultural industry is struggling,with high fue...ng the need,to secure the state,s energy independe...g adults., Nearly 900 guests gathered to hear the...ay Luncheon at Ag Progress Days, Pennsylvania,s,la...
(Date:8/20/2008)...n of brown globules helps burn calories, hints of ..., Aug. 20 (HealthDay News) -- A protein that induc...good" brown fat that helps burn calories and plays...he Joslin Diabetes Center in Boston. , They sai...ay help lead to new ways to prevent and treat obes...
Breaking Medicine News(10 mins):Health News:Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc. Magazine 2Health News:Liver Transplant Program Established At Montefiore 2Health News:Liver Transplant Program Established At Montefiore 3Health News:Liver Transplant Program Established At Montefiore 4Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Bone Growth Protein Also Promotes 'Good' Fat 2
...the Université de Montréal and the Centre hospital...ced an important breakthrough in fighting the// hu...me, scientists have identified a defect in the imm...he flaw. Dr. Rafick-Pierre Sékaly, an eminent rese...
...Medical Sciences (AIIMS) was Friday asked by a cit...untimely demise of a woman suffering// from heart ...sal Commission held the country's most prestigious...ble for gross negligence. The court asked AIIMS t...
...leaders approved the proposed discount drug plan, ...dications and 60% on generic ones for the// low-in...l require the prescription drug companies to enabl...uired to adhere to this by August 2010, failing wh...
...rdered administrations of all 30 districts to coll...the next three days.// The officials were Thursda...hubaneswar, said a senior health department offici...nt to a laboratory in Pune, Maharashtra, as the st...
Other Medicine News:Health News:Researchers Make a Major Strategic Breakthrough in Controlling the AIDS Virus 2
(Date:8/19/2008)... Aug. 19 /- Particle Sciences Inc. ha...olymers) development and,pilot production capabili...sion and injection molding line. The core of the p...ng extruder and Nissei 20T injection,molder, enabl...meric,devices. This addition gives Particle Scienc...
(Date:8/19/2008)... 19 /- Vical Incorporated,(...ration with the Karolinska,Institute, a leading Eu...te,for Infectious Disease Control (SMI), a governm...(R) adjuvant with the Biojector(R) 2000,needle-fre...nc.,OTCBB:BJCT) for a multivalent preventive DNA ...
(Date:8/18/2008)...offer hope for increased life expectancy for peopl...wire-USNewswire/ -- In the world of Down,syndrome,... has been,tracked for the past 16 years, at sevent...ectancy of a person with Down syndrome, currently ... was born. Further, ,Mr. C, does,not exhibit clini...
(Date:8/18/2008)... Clinical trial currently in Phase I -, PRINCETON...ra,Therapeutics Inc., a clinical stage biotechnolo...iscovery against life-threatening and life-alterin...e of Patent No. 7,371,772,B2 by the U.S. Patent an...,CCR5 antagonist currently in Phase I development ...
Breaking Medicine Technology:Particle Sciences Expands Its Combination Product Capabilities 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3Body image is stronger predictor of health than obesity says Mailman School of PH study 11719 1Body image is stronger predictor of health than obesity says Mailman School of PH study 11719 2 Respiratory Distress Treatment Studies Conflict 11715 1 Respiratory Distress Treatment Studies Conflict 11715 2 Respiratory Distress Treatment Studies Conflict 11715 3New Jefferson trial to test radiation emitting beads against advanced liver cancer 11710 1New Jefferson trial to test radiation emitting beads against advanced liver cancer 11710 2Dow AgroSciences Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3238 1Dow AgroSciences Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3238 2Dow AgroSciences Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3238 3Dow AgroSciences Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration 3238 4
...ed at the Congress of the European Hematology,Asso...tCall/ -- Favrille,Inc. , a biopharmaceutical com...rapies for the treatment of cancer, announced,inte... in patients,with indolent B-cell non-Hodgkin,s ly...ss of the European Hematology Association in,Vienn...
...stria, June 11, 2007 /PRNewswire/ -- GlaxoSmithKli...votal Phase III,study of its investigational non-p...ltrombopag olamine). Data from this study,showed t...tatistically significant increase in platelet coun...h chronic idiopathic,thrombocytopenic purpura (ITP...
Other Medicine Technology:Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 2Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 2Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 3Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 4Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 5Pivotal Phase III Trial Showed Promacta (eltrombopag olamine),Raised Platelet Counts and Reduced Bleeding in Patients With,Chronic ITP 6
Unit System Slide Cabinet is constructed from hardwood for long lasting.
Shandon Slide File Storage System
Shandon Microscope Slide Trays
... luminance white LED (Light Emitting Diode) light ..., to give you the freedom of using a slit lamp any...t 1.5 lbs. (0.68 kg) with its battery and fits eas...portable design and convenient carrying case make ...
Medicine Products: